Approval · Notice of Compliance 18542 · 2016
ORGARAN: Notice of Compliance 18542
Issued October 4, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18542
- Date
- October 4, 2016
- Company
- Aspen Pharma Trading Limited
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional manufacturing facility
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ORGARAN | Not yet assigned | — |
Medicinal ingredients
- DANAPAROID SODIUM 1,250 UNIT per ML